David E. Ehmann

Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor

David E. Ehmann, Haris Jahić, Philip L. Ross et al. · Proceedings of the National Academy of Sciences · 2012 · 507 citations · Full text

Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases

David E. Ehmann, Haris Jahić, Philip L. Ross et al. · Journal of Biological Chemistry · 2013 · 348 citations · Full text

D β-Lactamases, Antimicrobial Chemotherapy, Avibactam Inhibition +16

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 262 citations

Bacterial Resistance, Antimicrobial Susceptibility, Health Sciences +12

Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii

William F. Penwell, Adam B. Shapiro, R.A. Giacobbe et al. · Antimicrobial Agents and Chemotherapy · 2015 · 235 citations · Full text

Antibacterial Activity, Penicillin-binding Proteins, Sulbactam Antibacterial Activity +20

Lysine Biosynthesis in <i>Saccharomyces cerevisiae:  </i>Mechanism of α-Aminoadipate Reductase (Lys2) Involves Posttranslational Phosphopantetheinylation by Lys5

David E. Ehmann, Amy M. Gehring, Christopher T. Walsh · Biochemistry · 1999 · 160 citations